Personalized Prophylactic Treatment With Advate® in Severe or Moderate Haemophilia A Patients

NCT02622646 · clinicaltrials.gov ↗

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Hemophilia A
Factor VIII

Interventions

DRUG: Recombinant VIII factor

Sponsor

Hospital Universitario La Fe